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Abstract 
Muscle contraction is driven by the relative sliding of actin- and myosin-containing filaments. This process can be reconstituted in in 
vitro motility assays, where fluorescent actin filaments travel over a lawn of myosin heads. The velocity of the traveling actin filaments 
has been shown to depend strongly on the free adenosine triphosphate (ATP) concentration, but below 2-4/zM ATP, filament movement 
is consistently abolished. Here we report hat after a brief exposure of actomyosin to1 mM ATP, actin filament motility persists down to 
nanomolar ATP concentrations. 
Keywords: Actin filament; Heavy meromyosin; Motility assay, in vitro; ATP; Energy production, unexplained 
I. Introduction 
One of the unsolved problems of muscle contraction is
'unexplained' energy [1]. The work + heat produced ur- 
ing unloaded rapid muscle shortening exceeds the energy 
that can be accounted for by simultaneous ATP splitting. 
Indeed, Ohno and Kodama [2] reported that unloaded 
shortening of myofibrils occurs with no significant ATP 
turnover. The low ATPase values accompanying shorten- 
ing imply that the energy of ATP, at least in part, may be 
stored prior to contraction, and released gradually as the 
sarcomere shortens. 
An ideal method for addressing the issue of unexplained 
energy production is the in vitro motility assay [3,4]. 
Actin-filament translation over the field of myosin 
molecules is thought to be analogous to the unloaded 
shortening of muscle [5]. Thus, actin filaments might be 
expected to move in vitro at negligible actomyosin ATPase 
activities. Interestingly, however, the ATP-dependence of
filament velocity and actomyosin ATPase activity in the in 
vitro assay seems to show the opposite: the K m of ATPase 
activity is 4/zM ATP [4,6] (6 /zM for heavy meromyosin, 
HMM [6]), while that of filament velocity is 60 /~M [7] 
(88.3 /zM for HMM [5]). Thus, there is still significant 
ATP turnover below 2-4 /zM ATP, while actin filament 
motility is already abolished. 
One possible reason for this discrepancy is that experi- 
ments in the motility assay generally begin in the rigor 
state, where ATP is absent; then ATP is added to initiate 
motion. This situation is unnatural to the intact sarcomere, 
where ATP concentrations are consistently millimolar [8]. 
It has been shown that ATP causes conformational changes 
in both G- [9] and F-actin [10], and also in myosin [11]. 
Thus, by preexposing the contractile proteins in the motil- 
ity assay to 1 mM ATP initially, we could presumably 
create a situation analogous to that in the intact sarcomere. 
We find, in such a case, that motility can persist even if 
ATP is subsequently lowered to nanomolar levels. Prelimi- 
nary results of this work have been presented in the form 
of abstracts [12,13]. 
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2. Materials and methods 
2.1. Preparation of proteins 
Skeletal myosin was prepared from rabbit. 100 g of 
back muscle was processed according to the method of 
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Margossian and Lowey [14], with the following modifica- 
tions. After cooling on ice, the muscle was minced in a 
pre-cooled meat grinder. The muscle mince was then 
extracted with buffer containing 0.3 M KCI, 0.09 M 
KH2PO4, 0.06 M K2HPO 4 (pH 6.8), 0.2 mM ATP, 0.2 
mM dithiothreitol (DTT), and 0.23 mM phenylmethyl- 
sulfonyl fluoride (PMSF). After filtration through cheese- 
cloth, myosin was precipitated by diluting the filtrate ten 
times with ice-cold distilled water. The precipitated myosin 
was collected by centrifugation (20 000 X g, 4 ° C, 30 min), 
and the pellet was dissolved in 2 M KC1 and 0.5 M 
potassium phosphate (pH 6.8). The precipitation-dissolution 
cycle was repeated twice. The pellet of the final step was 
dissolved in 0.5 M KCI and 0.05 M potassium phosphate 
(pH 6.8), to yield a myosin concentration of 30 mg/ml. 
Myosin was then stored in 50% glycerol at - 20 ° C. Prior 
to further use, the stored myosin was further purified by a 
precipitation-dissolution cycle: 1 ml aliquot of myosin was 
precipitated with ice-cold 0.1 mM NaHCO 3, 0.1 mM 
EGTA and 1 mM DTF. The precipitated myosin was 
collected with low-speed centrifugation (5000 X g, 4 ° C, 
30 min), and the pellet was dissolved in equivalent volume 
of 20 mM imidazole-HC1 (pH 7.0), 1 M KC1, 4 mM 
MgC12, and 10 mM DTF. 
Heavy Meromyosin (HMM) was prepared fresh from 
stored myosin according to the steps described by Kron et 
al. [15]. Often, the HMM sample was actin-affinity puri- 
fied prior to the experiments o remove irreversible rigor 
heads. The purification was carried out according to Kron 
et al. [15]. 
Skeletal actin was prepared from rabbit back muscle by 
the method of Pardee and Spudich [16]. F-actin was fluo- 
rescently labelled with molar excess of tetramethyl- 
rhodamine-isothiocyanate-phalloidin (TRITC-Ph, Sigma 
Chemical Company, St. Louis, MO). Purity of the protein 
preparations was checked using electrophoresis. SDS-poly- 
acrylamide gel electrophoresis (SDS-PAGE) was per- 
formed according to Laemmli [17], using a 10% gel. 
Sigma SDS-6H kit was used as molecular-weight standard. 
2.2. In vitro motility assay 
The in vitro motility assay was performed essentially 
according to Kron et al. [15]. All experiments were per- 
formed at 30 ° C. Actin filaments were visualized in a Zeiss 
Axiovert epifluorescence microscope using a microchannel 
plate-intensified CCD camera (Electro-Optical Services, 
Charlottesville, VA), and the images were recorded using a 
computer-controlled Hi8mm video cassette recorder 
(SONY CCD-V5000). The time code was generated by an 
SMPTE time code generator (ESE, E1 Segundo, CA). 
Images from the tape were digitized by a QuickCapture 
frame-grabber board (Data Translation, Marlboro, MA). 
The images were processed with an Apple Macintosh Ilfx 
computer using the public domain NIH Image v.1.47 
program (written by Wayne Rasband at the US National 
Institutes of Health and available from the Internet by 
anonymous ftp from zippy.nimh.nih.gov r on floppy disk 
from NTIS, 5285 Port Royal Rd., Springfield, VA 22161, 
part number PB93-504868). Filament velocity was mea- 
sured by calculating the distance between coordinates of 
filament locations in successive digitized video images. 
Only filaments clearly moving on a path were evaluated. 
The flow-through microchamber was fabricated from a 
coverslip sandwich similar to the one described by War- 
shaw et al. [18], but modified as follows: first, a 22 X 40 
mm coverslip was coated with 0.5% nitrocellulose (in 
iso-amyl acetate). To achieve a microscopically smooth 
surface, we used the method of spin-coating. The method 
- widely used in the semiconductor industry for photore- 
sist coating of wafers [19] - yields a surface smoother than 
the underlying substrate [20]. 100 /zl nitrocellulose solu- 
tion was pipetted onto the center of the coverslip spinning 
at 1500 rpm. The spinning was continued for 30 s, until 
the coverslip was dry. A second modification was that two 
strips of silicone rubber (127 /zm thick, Dow Coming, 
Midland, MI) were placed on this coverslip arallel to each 
other so as to form a channel inbetween them, and a 
18 X 18 mm coverslip was placed on the silicone rubber 
'spacers.' Internal volume of the flow-through microcham- 
ber was approx. 10 /zl. 
Buffer conditions in the in vitro motility assay were 25 
mM imidazole-HCl (pH 7.4), 25 mM KC1, 4 mM MgC12, 
1 mM EGTA, 1 mM DTT. The solution was comple- 
mented with 0.5 mg/ml bovine serum albumin (BSA) to 
prevent nonspecific binding of actin to sites other than the 
myosin head; in some experiments, however, BSA was 
omitted from the buffer solution. To reduce photo- 
bleaching and the breakage of actin filaments, dissolved 
oxygen was scavenged by the addition of glucose oxidase 
(0.1 mg/mD, catalase (0.018 mg/ml), and glucose (3 
mg/ml) [21], and the solutions were degassed. HMM was 
infused in the microchamber at a concentration f at least 
50 /zg/ml to achieve saturation of the nitrocellulose sur- 
face. 30/xg/ml  HMM has been shown to be sufficient for 
saturation [22]. ATP concentration i  the in vitro motility 
assay was adjusted by dilution from a 300 mM ATP stock 
solution. The ATP stock solution was prepared by the 
following steps. The pH of the ATP solution was adjusted 
to 6.8, and its exact ATP concentration was measured 
spectrophotometrically. Aliquots of the solution were then 
rapidly frozen in liquid nitrogen, and stored at - 20 ° C for 
subsequent use. 
ATP-reduction in the microchamber was achieved by 
sequential washes with rigor solution (100 /zl each step). 
Washing of the microchamber was carried out by mi- 
cropipetting solution to one end of the flow cell while 
drawing solution from the other end with filter paper. 
During the washout procedure, new actin filaments were 
not added; the original filaments were followed through- 
out. Alternatively, ATP concentration was reduced enzy- 
matically, using apyrase (Grade V, Sigma Chemical Com- 
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Tris-HCl (pH 7.75)] or injected irectly into a luminometer 
(Packard, Laguna Hills, CA) containing a mixture of lu- 
ciferin and luciferase. The luminometer was calibrated by 
fresh dilution series of ATP (1 nM-1 mM) before and 
after the washout experiments. 
Scraping of the microchamber surface (for the purpose 
of collecting surface constituents) was accomplished by 
inserting agel-loading micropipet tip (100/xm outer diam- 
eter, Brinkmann Instruments, Westbury, NY) into the mi- 
crochamber. The pipet tip was moved laterally several 
times over the microchamber surface before drawing up 
the solution. 
2.4. Chemica ls  
All chemicals were reagent grade. ATP used was 'spe- 
cial quality' ATP from Boehringer Mannheim (Indianapo- 
lis, IN, stock No. 519 987). Luciferin and luciferase were 
the product of Coral Biomedical (San Diego, CA). 
Fig. 1. Stroboscopic image of actin filaments after three washes with 
rigor solution subsequent to pretreatment with 1 mM ATP. Successive 
video frames of fluorescent actin filaments were superimposed using 
image processing software (NIH Image v.1.47). The elapsed time be- 
tween individual frames i 3 s. Scale bar, 5 /xm. 
pany, St. Louis, MO, with an ADPase impurity 50% that 
of the ATPase activity). The apyrase experiments were 
carried out in the following way. First, ATP-digestion 
kinetics were established by monitoring the ATP concen- 
tration (by the luciferin luciferase method, see below) as a 
function of time. The apyrase level was adjusted so that 
the ATP concentration would fall from 1 mM to the 
nanomolar ange in not more than 10 min. Choosing 
slower kinetics impaired the extended visibility of actin 
filaments in the motility assay, and faster kinetics yielded 
inaccurate velocity measurements. After establishing the 
kinetics of ATP digestion, actin-filament velocities were 
measured as a function of time from the addition of 
apyrase. Using the established apyrase enzyme kinetics 
and filament velocities, the appropriate ATP-velocity 
curves were plotted. 
2.3. ATP  measurement  
Residual ATP in the microchamber was measured using 
the luciferin-luciferase assay [23]. After each rigor-solution 
wash, 10-~1 samples were collected by adding rigor solu- 
tion at one end of the microchamber and micropipetting 
from the other. Alternatively, the total content of the 
microchamber was collected. The collected samples were 
either diluted with assay buffer [0.5 mM MgSO 4 in 10 mM 
3. Results 
Upon the addition of 1 mM ATP, actin filaments began 
to move with an average velocity of 4.3 /zm/s. ATP 
concentration was then lowered by washing of the 10 /zl 
microchamber with 100/zl rigor solution (devoid of ATP). 
Interestingly, actin filament movement did not stop, but 
continued with an average velocity of 1.7 /zm/s. Upon 
further washes with rigor solution, filament motility per- 
sisted at progressively ower rates (Figs. 1, 2A). In fact, 
motility persisted after up to five washes with rigor solu- 
tion (0.07/zm/s). The characteristics of actin movement 
following washes were mostly similar to those after simple 
ATP activation: movement occurred uniformly across the 
coverslip and the extent of filament breakage was similar 
to that in the standard assay. However, the percentage of 
non-moving filaments increased. Using actin-affinity-puri- 
fied HMM reduced the fraction of non-moving filaments; 
however, the average velocity of the moving fraction did 
not change significantly. The use of a silicone-coated 
surface instead of nitrocellulose did not modify the result: 
filament movement persisted after multiple rigor-solution 
washes. Thus, contrary to the common expectation, infu- 
sion of vast amounts of rigor solution into the flow-through 
microchamber after ATP pretreatment did not halt the 
movement of actin filaments. 
We measured the amount of ATP remaining in the 
flow-through microchamber after each rigor-solution wash. 
Fig. 2B shows that ATP concentration was progressively 
reduced with each wash. After five washes the average 
remaining ATP concentration i  the microchamber was 8 
nM. 
As a control experiment, we attempted to induce actin- 
filament movement using ATP levels equal to the ones 
measured after the rigor-solution washes, but without the 
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ATP pretreatment. The result was identical to that of 
Harada et al. [7]: the filaments did not start to move until 
ATP concentration was raised above 1 /xM (Fig. 2C). 
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Motility, therefore, cannot be induced with ATP concentra- 
tion lower than 1 /zM, but can be sustained at ATP 
concentrations more than hundred times lower following a 
brief exposure to 1 mM ATP. 
In order to circumvent any uncertainties associated with 
the washout procedure, we implemented a different method 
to reduce ATP concentration: enzymatic digestion with 
apyrase. After determining the kinetics of ATP digestion 
by apyrase using the luciferin-luciferase assay, apyrase 
was added to the in vitro assay in the presence of 1 mM 
ATP. Actin filaments continued to move, though at a much 
reduced speed, at ATP concentrations down to 400 nM 
(Fig. 3). This concentration is 3-times lower than the 
threshold observed when ATP concentration was gradually 
increased, though not as low as found in the washout 
experiments. One possible reason for the discrepancy is 
that, unlike the washout protocol, apyrase digestion gener- 
ates ADP, which inhibits motility [5]. Thus, filaments may 
have stopped prematurely because of a partial ADP build- 
up in the microchamber. Qualitatively, however, the 
apyrase experiments upport the finding that following 
ATP pretreatment actin filaments move at lower-than- 
established ATP concentration. 
The hysteresis in the ATP-velocity curve (Fig. 2C) 
implies that ATP remains tored after the initial exposure 
to 1 mM ATP, and this can later be used to fuel actin 
movement. ATP could remain in large quantities near the 
microchamber surface, escaping the rigor-solution washes. 
This could occur via either of two mechanisms. First, a 
high concentration of ATP could remain in unstirred solu- 
tion layers near the microchamber surface, which would be 
a particularly realistic problem if a microscopically non-flat 
surface were used. In our case, however, the nitrocellulose 
surface was prepared by spin-coating that produces a flat 
surface, smoother than the underlying lass [20]. Further, 
upon collecting the total content of the microchamber 
(presumably including the unstirred solution layers), the 
measured ATP concentrations were as low as with the 
wash-through method. Thus, a high-concentration ATP 
source in the form of unstirred solution layers near the 
microchamber surface is unlikely. 
The second possible mechanism for storage of ATP is 
in the form of ATP bound to proteins on the microchamber 
surface. To check for this possibility, a different sample- 
collection technique was applied. 10-/zl samples were 
collected after scraping the chamber surface. Scraping 
Fig. 2. (a) Actin-filament velocity after different degrees of washing with 
rigor solution. (b) Residual ATP concentration i the flow-through mi- 
crochamber after different degrees of washing with rigor solution. (c) 
ATP-dependence of filament velocity in the case of ATP wash-in, and 
ATP wash-out. For the ATP wash-in data, velocities are plotted against 
the ATP concentrations of the wash-in solution; these concentrations 
were not significantly different from the concentrations i  the microcham- 
ber following wash-in. Error bars refer to standard eviations for n 
filaments. 
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Fig. 3. Effect of ATP depletion by apyrase on the velocity of actin 
filaments. The ATP concentrations were calculated from the ATP-di- 
gestion kinetics measured immediately before the motility assay. Error 
bars refer to standard eviations for n filaments. For the apyrase xperi- 
ments, pooled single observations of two experiments are shown. 
perturbs the microchamber surface, releasing surface con- 
stituents. Using this method, significantly higher quantities 
of ATP were collected (Fig. 4), indicating that ATP did 
bind to proteins on the microchamber surface. 
Of the proteins on the microchamber surface to which 
ATP could bind, the possibilities are: the two contractile 
proteins, or BSA. Actin is excluded, because we could 
obtain similar movement at nanomolar ATP when the 
HMM-coated surface was preexposed to the high ATP 
prior to the addition of actin. A more likely possibility is 
that the ATP pretreatment leaves behind the lawn of 
myosin heads saturated with ATP (HMM. ATP). When 
the free ATP concentration is subsequently owered by 
washing, the remaining high concentration f HMM. ATP 
could fuel motility. To check this possibility, we calculated 
the rate of decay of HMM. ATP, and compared it to the 
measured ecay in filament velocity (both following the 
third rigor-solution wash). If the initially high concentra- 
tion of HMM. ATP drives movement, the decay of 
HMM-bound nucleotide should result in a parallel decay 
of filament velocity. HMM-bound ATP is quickly hydro- 
lyzed to ADP and Pi, which remain associated with the 
myosin head, and can power motility [24]. The rate of 
HMM-nucleotide decay is thus determined by the dissocia- 
tion of the hydrolysis products. In the absence of actin, 
ADP and Pi dissociate from the myosin head with a rate 
constant of 0.05 s -1 [24]. Thus, within 20 s, 63% of the 
myosin heads lose their tightly bound nucleotide. The 
decay proceeds until an equilibrium is reached with the 
free ATP remaining in the microchamber (e.g., after the 
third wash, 100 nM). In the case of our densely HMM- 
coated microchamber, assuming a 100% initial saturation 
with ATP, this equilibrium is reached in about 85 s. At this 
time, only 1.4% of the myosin heads contain associated 
nucleotide. Thus, by 85 s, filament velocity is expected to 
drop by 98.6%. Further, in a recent work, Sowerby et al. 
[25] measured the rate of ATP turnover by myosin fila- 
ments under in vitro motility assay conditions. Their mea- 
surements yielded an even higher rate constant (0.064 s-1 
for skeletal myosin filaments). Considering the observa- 
tions of Sowerby et al. [25], actin-filament movement 
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Fig. 4. Comparison of the amounts of ATP collected with the washing 
(O) and scraping (O) methods. Scraping the microchamber surface 
yielded a release of 'surplus' ATP. Error bars refer to standard eviations 
for three experiments. 
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Fig. 5. Change in average filament velocity at 100 nM ATP concentration 
(after three rigor-solution washes), as a function of time. Error bars refer 
to standard eviations for five filaments. Curve was drawn by single 
exponential fit. Continued movement of actin filaments could be visually 
monitored for up to 15 minutes. At this time, however, the filaments were 
so faint and small that precise determination of their velocity was 
precluded. 
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should stop within a few tens of seconds following the 
third rigor-solution wash. By contrast, filament velocity 
hardly changed over a 10 min period; it decreased by less 
than 25% (Fig. 5). Thus, the HMM-bound nucleotide does 
not appear to be sufficient o support persistent motility. 
The third and final possibility is that a reservoir of 
stored ATP resides in BSA. Indeed, BSA binds ATP with 
high affinity (K d, 30-110 ~M) [26]. To test whether 
BSA-bound ATP serves as an ATP source for motility, we 
performed experiments where BSA was entirely omitted. 
We obtained results identical to the original observations; 
i.e., motility persisted after the rigor-solution washes. Two 
experiments were performed. Actin-filament velocity after 
the third rigor-solution wash - corresponding to a free 
ATP level of 135 nM - was found to be as high as 1.22 
/xm/s (___0.16, n = 14). Thus, any ATP bound to BSA 
during pre-exposure appears to be stable, and unavailable 
to fuel motility. 
4. Discussion 
In this work, we have shown that the in vitro motility of 
actin filaments over a lawn of HMM can persist at ATP 
concentrations down to the nanomolar range, provided that 
the acto-HMM is pretreated with ATP in the millimolar or 
' physiological' concentration range. In contrast, if the ATP 
concentration is increased from zero, filament movement 
begins only as the ATP concentration is raised above 1 
/xM, similarly to the previous results of Harada et al. [7]. 
Thus, one can observe different ATP-velocity functions 
depending on whether ATP concentration is being raised 
to, or decreased from, the 'physiological'. 
In an interesting contrast o our findings, the ATP 
dependence of tension generation by skinned single muscle 
fibers under isometric and low-Ca 2÷ conditions hows the 
opposite: when increasing ATP concentration from zero 
(rigor state), tension begins to rise at an ATP level as low 
as a few tens of nanomolar, and peaks at around 2 ~M 
[27,28]. Upon further increase in ATP, the muscle relaxes. 
When ATP is decreased from the millimolar concentration 
range (relaxed state), however, tension responses to stretch 
increase at as high an ATP level as 200 /~M [29]. The 
difference between the observations in the in vitro acto- 
myosin motility and the whole muscle fiber could be 
caused by several factors (e.g., presence of regulatory 
proteins and titin in the muscle fiber, unloaded conditions 
and low ionic strength in the in vitroassay versus isomet- 
ric conditions and high ionic strength in the muscle fiber). 
Nevertheless, the findings of Reuben et al. [27] and Gold- 
man et al. [28] indicate that the interaction of actin and 
myosin can indeed lead to contraction at submicromolar 
ATP concentrations. 
As far as the mechanism of the persisting in vitro actin 
motility is concerned, it might be caused by an ATP 
storage and release during the ATP pretreatment and sub- 
sequent washouts; alternatively, the phenomenon could be 
the result of a physiologically interesting mechanism, much 
like the one underlying the problem of 'unexplained en- 
ergy'. We examined the problem of ATP storage-release 
through a series of experiments, giving consideration to all 
candidates we could conceive of. However, our results 
imply that ATP stored during preexposure is largely un- 
available to drive subsequent motility. The amount avail- 
able must therefore be determined by the solution-ATP 
levels, which were extremely low. We explored the possi- 
bility that this low ATP level itself might be sufficient o 
drive motility. We did this by estimating the myosin step 
size - the amount of filament ranslation driven by each 
myosin head, per ATP split. This was calculated assuming 
Michaelis-Menten kinetics and using the approach of both 
Toyoshima et al. [30] and Harada et al. [31]. At 8 nM ATP 
and 0.07/~m/s average filament velocity, the approach of 
Toyoshima et al. [30] yielded a step size of 93 nm, while 
that of Harada et al. [31] gave 440 nm. (These calculations 
do not take into account the numerous nucleotide-free 
myosin heads expected at these low ATP levels, which 
will restrain motility. In the absence of such restraint, the 
step size would be even larger.) Since steps of this size are 
excessively arge according to current views [32], it is clear 
that the 8 nM ATP concentration is insufficient o drive 
motility. In order to fuel the motion observed at nanomolar 
ATP concentrations, therefore, some form of potential 
energy must be conferred to the system by the ATP 
pretreatment. 
The nature of the potential energy is not yet clear. The 
energy could be stored in actomyosin i the form of elastic 
or conformational energy [9-11,33]. Another possibility is 
that the ATP preexposure plenishes energy-rich phospho- 
ryl groups on the basic amino acids of myosin [34]. 
Alternatively, the preexposure could induce changes in the 
free energy of actomyosin's hydration shell [35]. A recent 
work by Elliott and Worthington [36] offers another mech- 
anism for a possible energy storage: the myosin molecule 
is charged by ATP in a slow process, and the discharge of 
myosin - hence the impulsive, force-generating step - 
takes place as a rapid process which can occur at a later 
time. An intriguing possibility within the framework of the 
cross-bridge mechanism is that the ATP pretreatment could 
'cock' the myosin heads, leaving them poised to stroke. 
Whatever the mechanism, the results imply energy stor- 
age: when ATP is diminished from an initially high level, 
motility persists at far lower ATP concentrations than 
when ATP is elevated from an initially low level. Func- 
tionally, this implies that in actomyosin motile systems, 
energy may be mobilized in advance of the contractile 
event. In the intact sarcomere, this advance mobilization 
could in principle account for the unexplained gap [1,2] 
between the energy delivered and the energy accounted for 
by concurrent splitting of ATP. The gap could be filled by 
the stored energy. 
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